Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 264 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Merck launches insomnia drug Belsomra in US

Orexin is one of the many neurotransmitters in the brain involved in promoting wakefulness, and Belsomra selectively blocks orexin receptors to suppress wake drive in the brain. The